Clinical outcomes
TG
SECONDARY
The primary clinical outcome was a change in the level of HbA1c over 84 days in the two treatment groups. The secondary clinical outcomes included the changes in the levels of FBG, 2hPBG, the area under curve of OGTT blood glucose, fasting insulin (FINS), 2-hour post-meal insulin (2hPINS), the area under curve of insulin release test, fasting C- peptide (FCP), 2-hour post-meal C-Peptide (2hPCP), the area under curve of C-peptide release test, total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), BW, WC, WHR, BMI, SBP, and DBP.